Table 5

Association of adult respiratory symptoms and lung function with parental smoking in childhood in 7799 women

Paternal smokingMaternal smokingMaternal smoking in pregnancyOne parent smokingBoth parents smokingDose- response
OR (95% CI)*p valueOR (95% CI)*p valueOR (95% CI)*p valueOR (95% CI)*OR (95% CI)*p value
Wheeze0.95 (0.83 to 1.08)0.41.15 (1.01 to 1.31)0.0321.39 (1.17 to 1.65)<0.0010.96 (0.84 to 1.10)1.09 (0.92 to 1.28)0.3
>3 asthma symptoms1.00 (0.87 to 1.14)0.91.16 (1.01 to 1.33)0.0401.42 (1.18 to 1.71)<0.0010.99 (0.85 to 1.16)1.16 (0.97 to 1.39)0.1
Current asthma0.84 (0.68 to 1.05)0.11.11 (0.88 to 1.40)0.41.28 (0.95 to 1.73)0.10.85 (0.66 to 1.08)0.94 (0.70 to 1.24)0.6
Chronic bronchitis1.02 (0.85 to 1.23)0.81.22 (1.01 to 1.46)0.0351.24 (0.97 to 1.58)0.0830.97 (0.79 to 1.19)1.28 (1.01 to 1.61)0.040
β coeff (95% CI)†p valueβ coeff (95% CI)†p valueβ coeff (95% CI)†p valueβ coeff (95% CI)†β coeff (95% CI)†p value
*Odds ratios with 95% confidence intervals as estimated by logistic regression adjusting for age, body mass index, number of siblings, current smoking, current environmental tobacco smoking, current occupation, and study centre.
†Analysed with adjustment for height, age, weight, weight squared, number of siblings, current smoking, current environmental tobacco smoking, current occupation, and study centre.
FEV1 (ml)4 (−16 to 24)0.7−24 (−46 to −3)0.025−23 (−52 to 7)0.10 (−21 to 22)−19 (−46 to 7)0.2
FVC (ml)5 (−18 to 28)0.7−3 (−27 to 21)0.813 (−21 to 47)0.55 (−19 to 30)4 (−26 to 34)0.8
FEV1/FVC ratio (%)−0.1 (−0.4 to 0.2)0.6−0.6 (−0.9 to −0.3)<0.001−0.9 (−1.3 to −0.4)<0.001−0.1 (−0.5 to 0.2)−0.7 (−1.1 to −0.3)0.001
BHR (ECRHS slope)0.02 (−0.10 to 0.14)0.70.01 (−0.12 to 0.14)0.9−0.03 (−0.21 to 0.15)0.70.04 (−0.09 to 0.17)0.03 (−0.13 to 0.19)0.7